 |
Top Earnings NewsAGNC Investment Missed Expectations AGNC Investment (AGNC) reported earnings of $0.35 per share on revenue of $903.00 million for the third quarter ended September 2025. The consensus earnings estimate was $0.38 per share on revenue of $270.00 million. The Earnings Whisper number was $0.40 per share. The company missed expectations by 12.50% while revenue grew 19.44% on a year-over-year basis.
"In the third quarter, the Federal Reserve's pivot to a less restrictive monetary policy stance and the easing of fiscal policy concerns drove robust financial market performance and a significant improvement in investor sentiment," said Peter Federico, the Company's President, Chief Executive Officer and Chief Investment Officer. "Agency mortgage-backed securities were one of the best performing fixed income asset classes during the quarter and have now outperformed U.S. Treasuries for five consecutive months for the first time since 2013. In this beneficial investment environment, AGNC generated a very strong economic return on tangible common equity of 10.6% in the third quarter.
American Capital Agency Corp is a real estate investment trust that invests exclusively in residential mortgage pass-through securities and collateralized mortgage obligations on a leveraged basis.
|
Positive GuidanceCorMedix Raises Guidance CorMedix, Inc. (CRMD) said it expects third-quarter revenue of more than $125.0 million. The current consensus revenue estimate is $66.1 million for the quarter ending September 30, 2025. The company also said it now expects 2025 revenue of at least $375.0 million. The company's previous guidance was revenue of $325.0 million to $350.0 million, but the current consensus revenue estimate is $249.0 million for the year ending December 31, 2025.
Cormedix Inc is a development stage pharmaceutical and medical device company. It seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases, including the dialysis and non-dialysis areas.
View All Guidance
Crown Raises Guidance Crown Holdings, Inc. (CCK) said it expects 2025 earnings of $7.70 to $7.80 per share. The company's previous guidance was earnings of $7.10 to $7.50 per share and the current consensus earnings estimate is $7.38 per share for the year ending December 31, 2025.
Crown Holdings Inc is engaged in the design, manufacture and sale of packaging products for consumer goods. The Company’s primary products include steel & aluminum cans for food, beverage, household and other consumer products and metal vacuum closures.
Other Top Guidance Announcements |
Positive SurpriseFlexsteel Industries Beat Consensus Estimates Flexsteel Industries (FLXS) reported earnings of $1.31 per share on revenue of $110.44 million for the fiscal first quarter ended September 2025. The consensus earnings estimate was $0.78 per share on revenue of $105.38 million. The company beat consensus estimates by 67.95% while revenue grew 6.18% on a year-over-year basis.
Flexsteel Industries, Inc., and Subsidiaries, is one of the largest manufacturers, importers, and marketers of residential furniture products in the United States.
View All Earnings
Negative SurpriseSummit Therapeutics Plc Missed Expectations Summit Therapeutics Plc (SMMT) reported a loss of $0.31 per share on revenue of $0.00 million for the third quarter ended September 2025. The consensus estimate was a loss of $0.14 per share on revenue of $27.76 million. The Earnings Whisper number was a loss of $0.16 per share. The company missed expectations by 93.75%.
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs.
|
|
Netflix is Expected to Beat Estimates Netflix (NFLX) is confirmed to report earnings on Tuesday, October 21, 2025 at approximately 4:00 PM ET. The consensus earnings estimate is $6.89 per share on revenue of $11.52 billion, respresenting 17.3% year-over-year revenue growth, and the Earnings Whisper ® number is $6.96 per share. Investors are 52.2% bullish going into the company's earnings release. Option traders are pricing in a 8.1% move on earnings and the stock has averaged a 6.3% move in recent quarters.
View Full Calendar
|
|
